Compare · HIMS vs PRVA
HIMS vs PRVA
Side-by-side comparison of Hims & Hers Health Inc. (HIMS) and Privia Health Group Inc. (PRVA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HIMS and PRVA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.85B, about 2.4x PRVA ($2.89B).
- HIMS has been more active in the news (10 items in the past 4 weeks vs 2 for PRVA).
- Both have 25 recent analyst ratings on file.
- Company
- Hims & Hers Health Inc.
- Privia Health Group Inc.
- Price
- $28.05-4.54%
- $22.53-0.40%
- Market cap
- $6.85B
- $2.89B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2021
- News (4w)
- 10
- 2
- Recent ratings
- 25
- 25
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Privia Health Group Inc.
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
Latest HIMS
- SEC Form 4 filed by Hims & Hers Health Inc.
- SEC Form 3 filed by Hims & Hers Health Inc.
- Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
- Hers Launches in Australia, Built to Care for the Whole Woman
- SEC Form 8-K filed by Hims & Hers Health Inc.
- Hims & Hers Names Jon Franklin as Chief Accounting Officer
- Chief Financial Officer Okupe Oluyemi sold $59,400 worth of shares (2,000 units at $29.70) as part of a pre-agreed trading plan, decreasing direct ownership by 0.85% to 234,527 units (SEC Form 4)
- Chief Legal Officer Boughton Soleil sold $100,957 worth of shares (3,461 units at $29.17) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 300,809 units (SEC Form 4)
- Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
- Chief Financial Officer Okupe Oluyemi sold $876,846 worth of shares (29,277 units at $29.95) as part of a pre-agreed trading plan and exercised 14,000 shares at a strike of $5.01, decreasing direct ownership by 6% to 236,527 units (SEC Form 4)
Latest PRVA
- Privia Health to Report Third Quarter 2026 Results on Thursday, November 5
- Amendment: SEC Form SCHEDULE 13G/A filed by Privia Health Group Inc.
- Director Ernest Opella Finley was granted 6,350 shares (SEC Form 4)
- SEC Form 3 filed by new insider Ernest Opella Finley
- Privia Health Group Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors
- SEC Form 10-Q filed by Privia Health Group Inc.
- Privia Health Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results
- EVP & Chief Financial Officer Mountcastle David sold $588,679 worth of shares (21,275 units at $27.67) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 164,853 units (SEC Form 4)